| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/28/1994 | CA2145204A1 Antibiotic agents |
| 04/28/1994 | CA2145203A1 Amino acid conjugates of cyclohexapeptidyl amines |
| 04/28/1994 | CA2109159A1 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component |
| 04/27/1994 | EP0594284A2 Antibody containing pharmaceutical composition against aids |
| 04/27/1994 | EP0594263A1 Thioalkylthio cephalosporin derivatives and intermediates |
| 04/27/1994 | EP0593901A2 Oligoribonucleotide- and ribozyme-analoguer with terminal 3',3'- and 5',5'-bonds respectively |
| 04/27/1994 | EP0593766A1 Pyridonecarboxylic acid derivative |
| 04/27/1994 | EP0593754A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 04/27/1994 | EP0593562A1 Tropical composition containing penciclovir |
| 04/27/1994 | EP0593536A1 DIBENZ b,e]AZEPINE DERIVATIVES AND DRUGS CONTAINING THEM |
| 04/27/1994 | EP0593457A1 Antimicrobial quinolone thioureas |
| 04/27/1994 | EP0462145B1 Covalent conjugates of lipid and oligonucleotide |
| 04/27/1994 | EP0460034B1 Novel vitamin d analogues |
| 04/27/1994 | EP0422097B1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
| 04/27/1994 | CN1085908A Liponucleotides of seco-nucleosides, processes for the preparation thereof and pharmaceutical compositions with antiviral action containing them |
| 04/27/1994 | CN1085805A Vaccine compositions |
| 04/26/1994 | US5306837 Antiviral agents |
| 04/26/1994 | US5306816 Processes for preparing carbapenem derivatives |
| 04/26/1994 | US5306732 Administering vinigrol |
| 04/26/1994 | US5306722 Thymidine derivatives and therapeutic method of use |
| 04/26/1994 | US5306717 Cephalosporin derivatives |
| 04/26/1994 | US5306715 Storage stability |
| 04/26/1994 | US5306708 Antibiotic agent |
| 04/26/1994 | US5306635 DNA encoding immunogenic gpIII glycoprotein of varicella-zoster virus |
| 04/26/1994 | US5306482 Benz(alk or eth)orium chloride |
| 04/26/1994 | CA1328865C Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabino- furanosyl)-5-ethyluracil |
| 04/20/1994 | EP0593339A1 Process preparation of hepatitis A antigen and vaccine |
| 04/20/1994 | EP0593290A2 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/20/1994 | EP0593093A1 Treatment of hair loss |
| 04/20/1994 | EP0592904A1 Topical stable compositions with good active agent release capability and containing at least a lipophilized macrolide antibiotic |
| 04/20/1994 | EP0592643A1 Pleuromutilin derivatives |
| 04/20/1994 | EP0592634A1 Inhibitor of protein kinase c |
| 04/20/1994 | EP0592546A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 04/20/1994 | EP0592480A1 Papillomavirus l2 protein |
| 04/20/1994 | EP0592464A1 Chemotactic factor |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/20/1994 | CN1085550A New quinazolines as inhibitors of HIV reverse transcriptase |
| 04/20/1994 | CN1085450A Vaccines |
| 04/20/1994 | CN1085447A Agent for promoting of phagocyte |
| 04/19/1994 | US5304633 Fragments of lactoferrin having potent antimicrobial activity |
| 04/19/1994 | US5304559 Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 04/19/1994 | US5304551 Anti-fungal compounds |
| 04/19/1994 | CA1328623C2 Antibacterial antiplaque, anticalculus oral composition |
| 04/19/1994 | CA1328616C Use of the thiazole derivative tiprotimod for the preparation of an agent for the therapy of virus infections |
| 04/19/1994 | CA1328609C Antibiotic-polymer compositions |
| 04/14/1994 | WO1994008053A1 Oligonucleotides having a conserved g4 core sequence |
| 04/14/1994 | WO1994008022A1 Vector to deliver and express foreign gene |
| 04/14/1994 | WO1994008021A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| 04/14/1994 | WO1994008004A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 04/14/1994 | WO1994008002A2 Methods and compositions for controlling translation of hcv proteins |
| 04/14/1994 | WO1994008000A1 Pseudorabies virus vaccine |
| 04/14/1994 | WO1994007922A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | WO1994007898A1 Novel cephalosporin derivatives and processes for the preparation thereof |
| 04/14/1994 | WO1994007892A1 Process for the preparation of 2-amino-6-chloropurine |
| 04/14/1994 | WO1994007875A1 Heterocyclic amines having colmodulin antagonist properties |
| 04/14/1994 | WO1994007873A1 Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof |
| 04/14/1994 | WO1994007853A1 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 04/14/1994 | WO1994007837A1 Unsaturated aliphatic dicarboxylic acids |
| 04/14/1994 | WO1994007531A1 Method of enhancing cell mediated immune responses |
| 04/14/1994 | WO1994007525A1 Antiviral agent |
| 04/14/1994 | WO1994007523A1 Antimicrobial peptides |
| 04/14/1994 | WO1994007512A1 Royal jelly |
| 04/14/1994 | WO1994007504A1 New pharmaceutical formulations of spiramycine |
| 04/14/1994 | WO1994007495A1 Use of norastemizole for the treatment of allergic disorders |
| 04/14/1994 | WO1994007480A1 Polyamine derivatives as anti-cytomegaloviral agents |
| 04/14/1994 | WO1994007479A2 Immunopotentiatory agents |
| 04/14/1994 | CA2146364A1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 04/14/1994 | CA2146319A1 Polyamine derivatives as anti-cytomegaloviral agents |
| 04/14/1994 | CA2146251A1 New pharmaceutical spiramycin formulations |
| 04/14/1994 | CA2146163A1 Heterocyclic amines calmodulin antagonist properties |
| 04/14/1994 | CA2145760A1 Method of enhancing cell mediated immune responses |
| 04/14/1994 | CA2145757A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | CA2125287A1 Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives |
| 04/13/1994 | EP0592167A1 Antibiotic pyrrolidinylthiopenem derivatives |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591914A2 Retrovirus of the HIV-group and its application |
| 04/13/1994 | EP0591808A1 Quinolonecarboxylic acids |
| 04/13/1994 | EP0591603A2 Antimicrobial agent for staphylococcus comprising an extract of Ganoderma Lucidum |
| 04/13/1994 | EP0591483A1 Albumin-iodine preservation of blood, tissues and biological fluids |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591384A1 Attenuated revertant serotype 1 marek's disease vaccine |
| 04/13/1994 | EP0591303A1 Methods and compositions for treating malaria and other diseases |
| 04/13/1994 | EP0591281A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 04/13/1994 | EP0538300B1 O-glycosylated ifn-alpha |
| 04/13/1994 | CN1085214A Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these |
| 04/13/1994 | CN1085102A Streptococcus antibiotic |
| 04/13/1994 | CN1085101A Antimicrobial agent for staphylococcus |
| 04/12/1994 | US5302712 Used for making pharmceutical compositions for treating infectious diseases |
| 04/12/1994 | US5302711 Deesterification of the blocked 3- or 4-carboxylate derivative of cepham or penam with lithium iodide in a nonbasic solvent having a dielectric constant of between 0 and 15 |
| 04/12/1994 | US5302705 6-O-methylerythromycin a oxime derivatives |
| 04/12/1994 | US5302588 Antibacterial agent |
| 04/12/1994 | CA1328406C Anti-inflammatory and antimicrobial formulations for dermatalogic and inflammatory diseases |
| 04/12/1994 | CA1328405C Pharmaceutical composition |
| 04/12/1994 | CA1328404C Pharmaceutical combination product and the preparation and use thereof |
| 04/10/1994 | CA2107812A1 Quinolone carboxylic acids |
| 04/08/1994 | CA2106330A1 Antibiotic compounds |
| 04/06/1994 | EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
| 04/06/1994 | EP0590610A1 Novel benzothiazole derivatives and processes for preparing the same |